CS MEDICA A/S Stock

Equities

CSMED

DK0061668225

End-of-day quote NORDIC GROWTH MARKET Other stock markets 2024-12-05			5-day change	1st Jan Change
6.952 ^DKK	-9.56%		-8.06%	+48.46%

Dec. 02	CS Medica increases turnover and operating profit	FW
Nov. 30	CS Medica A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024	CI

Valuation: CS MEDICA A/S

Capitalization	62.26M 8.83M 8.35M 7.76M 6.92M 12.38M 748M 13.71M 95.98M 35.61M 306M 33.13M 32.42M 1.33B	P/E ratio 2024	-16x	P/E ratio 2025 *	-12.6x
Enterprise value	91.16M 12.92M 12.23M 11.36M 10.13M 18.13M 1.09B 20.07M 141M 52.13M 448M 48.5M 47.47M 1.94B	EV / Sales 2024	10.2x	EV / Sales 2025 *	2.98x
Free-Float	-	Yield 2024 *	-	Yield 2025 *	-

More valuation ratios * Estimated data

Chart: CS MEDICA A/S

Timeframe

Style

Dynamic Chart

Latest news: CS MEDICA A/S

CS Medica increases turnover and operating profit	Dec. 02	FW
CS Medica A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024	Nov. 30	CI
CS Medica A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024	Nov. 30	CI
CS Medica's distribution of shares in Cannordic delayed	Nov. 22	FW
CS Medica welcomes proposal to make medical cannabis pilot program permanent	Nov. 22	FW
CS Medica postpones interim report to November 30	Nov. 13	FW
CS Medica explains strategic motives behind Cannordic IPO / capital increase	Nov. 12	FW
CS Medica Unit Signs Distribution Deal With Ukraine's Deutsch-Pharm	Nov. 11	MT
CS Medica signs agreement in Ukraine with a sales potential of DKK 0.75 million	Nov. 11	FW
Nuways initiates coverage of CS Medica with buy recommendation (update)	Nov. 04	FW
Nuways initiates coverage of CS Medica with a buy recommendation	Nov. 04	FW
CS Medica has completed classification for MDR compliance	Oct. 29	FW
CS Medica can finalize agreements after sales approval - signs agreement in South Africa	Oct. 02	FW

More news

Last Transcript: CS MEDICA A/S

CS Medica A/S, H1 2024 Earnings Call, May 23, 2024

May. 23

More transcripts

Analysts' recommendations: CS MEDICA A/S

Nuways initiates coverage of CS Medica with buy recommendation (update)	Nov. 04	FW
Nuways initiates coverage of CS Medica with a buy recommendation	Nov. 04	FW

More recommendations

Press Releases: CS MEDICA A/S

CS MEDICA: CS MEDICA: Q4 Interim report, July – September 2024	Nov. 30	PU
CS MEDICA: Q4 Interim report, July - September 2024	Nov. 30	AQ
CS MEDICA: Update on the Share Distribution of CANNORDIC Shares	Nov. 22	PU
Update on the Share Distribution of CANNORDIC Shares	Nov. 22	AQ
CS MEDICA: CS MEDICA Welcomes the Danish Government's Proposal to Make the Pilot Program for Prescription-Based Medicinal Cannabis Permanent	Nov. 22	PU

More press releases

News in other languages: CS MEDICA A/S

CS MEDICA A/S (von NuWays AG): Buy	Nov. 04
CS MEDICA Aktie wird jetzt auch auf XETRA gehandelt	Jul. 01
CS MEDICA Aktie wird jetzt auch auf XETRA gehandelt	Jul. 01
CS MEDICA Group erhält Zulassung seines kompletten Portfolios aus der CANNASEN® Produktreihe CBD-haltiger Therapien in Israel	Jun. 17
CS MEDICA Group erhält Zulassung seines kompletten Portfolios aus der CANNASEN® Produktreihe CBD-haltiger Therapien in Israel	Jun. 17

More news

Quotes and Performance

1 day	-9.56%
1 week	-8.06%
Current month	-10.01%
1 month	+6.18%
3 months	-33.96%
6 months	+37.78%
Current year	+48.46%

More quotes

Course Extremes

1 week

6.18

8.42

1 month

5.58

8.42

Current year

3.36

18.00

1 year

3.07

18.00

3 years

3.05

29.94

5 years

3.05

29.94

10 years

3.05

29.94

More quotes

Managers and Directors: CS MEDICA A/S

Director	Title	Age	Since
Lone Henriksen CEO	Chief Executive Officer	54	2011-08-06
Gitte Lund Henriksen DFI	Director of Finance/CFO	57	2011-08-06
Heidi Ahlefeldt-Laurvig COO	Chief Operating Officer	51	-

Manager	Title	Age	Since
Jorgen Flemming Ladefoged CHM	Chairman	54	2020-12-31
Gitte Lund Henriksen BRD	Director/Board Member	57	2020-12-31
Anders Permin BRD	Director/Board Member	61	2020-12-31

More insiders

Financials

	2024	2025 *
Net sales	16.1M 2.28M 2.16M 2.01M 1.79M 3.2M 193M 3.54M 24.82M 9.21M 79.21M 8.57M 8.38M 343M	33.8M 4.79M 4.53M 4.21M 3.76M 6.72M 406M 7.44M 52.1M 19.33M 166M 17.98M 17.6M 719M
Net income	-14.7M -2.08M -1.97M -1.83M -1.63M -2.92M -177M -3.24M -22.66M -8.41M -72.32M -7.82M -7.65M -313M	-9.3M -1.32M -1.25M -1.16M -1.03M -1.85M -112M -2.05M -14.34M -5.32M -45.75M -4.95M -4.84M -198M
Net Debt	28.9M 4.1M 3.88M 3.6M 3.21M 5.75M 347M 6.36M 44.55M 16.53M 142M 15.38M 15.05M 615M	38.5M 5.46M 5.16M 4.8M 4.28M 7.66M 462M 8.48M 59.35M 22.02M 189M 20.48M 20.05M 819M